Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tormod Fladby

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Neuroimage|February 2, 2013
Correction of partial volume effect in (18)F-FDG PET brain studies using coregistered MR volumes: voxel based analysis of tracer uptake in the white matterChristopher Coello, Frode Willoch, Per Selnes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2025
Neurofilament light chain - a marker of neuronal injuryTrygve Holmøy, Ingrid Marie Hardang, Tormod Fladby, et al.
Neuroscience Letters|August 6, 2002
Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophreniaLennart Wetterberg, Rolf Nybom, Trond Bratlid, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF BiomarkersRamune Grambaite, Erik Hessen, Eirik Auning, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 17, 2011
[New diagnostic criteria for Alzheimer disease]Dag Aarsland, Arvid Rongve, Tormod Fladby, et al.
Clinical Chemistry|October 24, 2009
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer diseaseSonia Chalbot, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|July 28, 2025
Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassaysJoyce Ruifen Chong, Abdul Hye, Mercè Boada, et al.
Neuroscience Letters|May 18, 2010
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeabilitySonia Chalbot, Henrik Zetterberg, Kaj Blennow, et al.
Dementia and Geriatric Cognitive Disorders|October 24, 2008
White matter lesion subtypes and cognitive deficits in patients with memory impairmentVidar Stenset, Dag Hofoss, Audun Elnaes Berstad, et al.
Brain and Behavior|September 27, 2017
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive declineCarl F Eliassen, Ivar Reinvang, Per Selnes, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Neuroimage|February 2, 2013
Correction of partial volume effect in (18)F-FDG PET brain studies using coregistered MR volumes: voxel based analysis of tracer uptake in the white matterChristopher Coello, Frode Willoch, Per Selnes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2025
Neurofilament light chain - a marker of neuronal injuryTrygve Holmøy, Ingrid Marie Hardang, Tormod Fladby, et al.
Neuroscience Letters|August 6, 2002
Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophreniaLennart Wetterberg, Rolf Nybom, Trond Bratlid, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF BiomarkersRamune Grambaite, Erik Hessen, Eirik Auning, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 17, 2011
[New diagnostic criteria for Alzheimer disease]Dag Aarsland, Arvid Rongve, Tormod Fladby, et al.
Clinical Chemistry|October 24, 2009
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer diseaseSonia Chalbot, Henrik Zetterberg, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|July 28, 2025
Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassaysJoyce Ruifen Chong, Abdul Hye, Mercè Boada, et al.
Neuroscience Letters|May 18, 2010
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeabilitySonia Chalbot, Henrik Zetterberg, Kaj Blennow, et al.
Dementia and Geriatric Cognitive Disorders|October 24, 2008
White matter lesion subtypes and cognitive deficits in patients with memory impairmentVidar Stenset, Dag Hofoss, Audun Elnaes Berstad, et al.
Brain and Behavior|September 27, 2017
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive declineCarl F Eliassen, Ivar Reinvang, Per Selnes, et al.
Pageof 17